In conclusion, our study shows that hypoxia significantly contributes to the metastatic potential of SS cells by activating a cascade of molecular changes (HIF-1 targets, YB-1, TGF-β1, IGF2) that promote angiogenesis, invasion, and survival. The gene discussed is TGFB1; the disease is synovial sarcoma.